Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ShahSultan Mirshahi

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Thrombosis Research|January 15, 2013
Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxabanRémi Varin, Shahsultan Mirshahi, Pezhman Mirshahi, et al.
Thrombosis and Haemostasis|January 4, 2007
Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activityRémi Varin, Shahsultan Mirshahi, Pezhman Mirshahi, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Thrombosis Research|January 15, 2013
Whole blood clots are more resistant to lysis than plasma clots--greater efficacy of rivaroxabanRémi Varin, Shahsultan Mirshahi, Pezhman Mirshahi, et al.
Thrombosis and Haemostasis|January 4, 2007
Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activityRémi Varin, Shahsultan Mirshahi, Pezhman Mirshahi, et al.
Pageof 1